Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
The Journal of Infectious Diseases
|
September 22, 2017
A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance
Will Stone, Patrick Sawa, Kjerstin Lanke, et al.
BMJ Global Health
|
July 1, 2021
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial
Sibonakaliso Vilakati, Nontokozo Mngadi, Jade Benjamin-Chung, et al.
Nature Medicine
|
May 6, 2024
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
Deus S Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Ebiomedicine
|
December 10, 2024
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia
Henry Ntuku, Brooke Whittemore, Lucille Dausab, et al.
Plos Medicine
|
August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data
Leen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Lancet (London, England)
|
December 14, 2024
Regional action needed to halt antimalarial drug resistance in Africa
Rosario Martinez-Vega, Deus S Ishengoma, Roly Gosling, et al.
The Lancet. Infectious Diseases
|
February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
Alassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
Nature Communications
|
May 9, 2025
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Eclinicalmedicine
|
February 24, 2022
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial
Lindsey Wu, Michelle S Hsiang, Lisa M Prach, et al.
Malaria Journal
|
August 20, 2025
Occupations at high risk for malaria in Zanzibar: a case-control study, may-august 2023
Geofrey Makenga, Sarah Gallalee, Humphrey Mkali, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
The Journal of Infectious Diseases
|
September 22, 2017
A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance
Will Stone, Patrick Sawa, Kjerstin Lanke, et al.
BMJ Global Health
|
July 1, 2021
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial
Sibonakaliso Vilakati, Nontokozo Mngadi, Jade Benjamin-Chung, et al.
Nature Medicine
|
May 6, 2024
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
Deus S Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Ebiomedicine
|
December 10, 2024
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia
Henry Ntuku, Brooke Whittemore, Lucille Dausab, et al.
Plos Medicine
|
August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data
Leen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Lancet (London, England)
|
December 14, 2024
Regional action needed to halt antimalarial drug resistance in Africa
Rosario Martinez-Vega, Deus S Ishengoma, Roly Gosling, et al.
The Lancet. Infectious Diseases
|
February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
Alassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
Nature Communications
|
May 9, 2025
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Eclinicalmedicine
|
February 24, 2022
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial
Lindsey Wu, Michelle S Hsiang, Lisa M Prach, et al.
Malaria Journal
|
August 20, 2025
Occupations at high risk for malaria in Zanzibar: a case-control study, may-august 2023
Geofrey Makenga, Sarah Gallalee, Humphrey Mkali, et al.
Page
of 12